Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Vigo – page 19

308 clinical trials in Vigo, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Vigo at a glance
308
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

308 trials in Vigo

Open in trial search

Study on the Safety and Effectiveness of Elafibranor for Adults with Primary Sclerosing Cholangitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB

Hypersensitivity

Not recruiting

Study on Allergenic Extracts of Mites and Histamine Dihydrochloride for Allergy Patients

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Blomia Tropicalis
  • Sponsor:Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.

Partial seizures

Not recruiting

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Fallopian tube cancer+2

Not recruiting

Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Nemvaleukin Alfa
  • Sponsor:Mural Oncology Inc.

HIV infection

Not recruiting

Study Comparing DTG/3TC and BIC/FTC/TAF for Maintaining HIV Control in Adults

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Fundacion Seimc Gesida

Study on the Effects of Satralizumab for Patients with Autoimmune Encephalitis (NMDAR or LGI1)

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Study on Elafibranor for Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Pharma

Study of MEN1611 and Eribulin for Advanced Metaplastic Breast Cancer in Patients with PIK3CA/PTEN Alterations

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Eribulin
  • Sponsor:Medica Scientia Innovation Research S.L.

Breast cancer

Not recruiting

Study on Trastuzumab Deruxtecan and Drug Combination for Patients with High-Risk HER2-Positive Early Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AstraZeneca AB

Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Region Skane

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Vigo

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on various cancer treatments, including studies for gastric cancer, non-small cell lung cancer, and breast cancer. Research involves combination therapies and novel treatment approaches.

  • Advanced gastric and gastroesophageal cancer treatments
  • Targeted therapies for lung cancer
  • Triple-negative breast cancer interventions

Multiple studies evaluating immunotherapy combinations and chemotherapy protocols for improved patient outcomes.

02 Infectious Diseases

Comprehensive research programs examining treatments for HIV infections and influenza, including preventive measures and therapeutic interventions.

  • HIV pre-exposure prophylaxis studies
  • Influenza vaccine efficacy trials
  • Antiviral therapy evaluations

Focus on developing improved prevention strategies and treatment options for viral infections.

03 Cardiovascular Research

Studies investigating treatments for heart failure prevention and atrial fibrillation, with emphasis on innovative therapeutic approaches.

  • Heart failure risk reduction studies
  • Anticoagulation therapy research
  • Cardiovascular disease prevention

Evaluating new drug combinations and treatment strategies for improved cardiac outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.